ZTS
🐶 Zoetis is a global leader in animal health, with a wide range of products for pets and livestock.
📈 The animal health market is expected to expand by 4-6% annually, reaching $90 billion by 2033.
🔬 The company has 15 medicines generating over $100 million in annual sales each.
💸 Lower interest rates allow Zoetis to invest more in research and development, accelerating innovation.
@rankia:
“Zoetis, ZTS, is a global leader in animal health, specializing in medicines, vaccines, diagnostics, and other solutions for pets and livestock. With over 70 years of experience, Zoetis has 15 medicines that generate more than $100 million in annual sales each. The market is expected to expand between 4% and 6% annually, potentially reaching $90 billion by 2033. Current trends favor Zoetis, including the growing bond between humans and animals, innovation in treatments for chronic diseases, and the global need for more protein. With lower interest rates, Zoetis can invest more in research and development, accelerating innovation and maintaining its leadership in the sector.”
Watch the exact part of the video where Rankia talks about Zoetis here:
View the video on YouTube.
Read more articles by the world’s top 100 analysts on Zoetis (ZTS) at the following link. ZTS stock.
